Are you Dr. Zhao?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 16 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
8118 Good Luck Rd
Lanham, MD 20706Phone+1 301-552-8149
Summary
- Dr. Bin Zhao, MD is a board certified pathologist in Lanham, Maryland. He is currently licensed to practice medicine in Maryland, Virginia, and District of Columbia. He is affiliated with Luminis Health Doctors Community Medical Center and Holy Cross Hospital.
Education & Training
George Washington UniversityResidency, Pathology-Anatomic and Clinical, 2012 - 2016
Conemaugh Memorial Medical CenterResidency, Pathology-Anatomic and Clinical, 2012 - 2016
Shanxi Medical UniversityClass of 1985
Certifications & Licensure
VA State Medical License 2017 - 2026
MD State Medical License 2019 - 2025
PA State Medical License 2012 - 2024
DC State Medical License 2012 - 2016- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Clinical Trials
- Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis Start of enrollment: 2017 Jan 01
Publications & Presentations
PubMed
- 1824 citationsTEAD mediates YAP-dependent gene induction and growth controlBin Zhao, Xin Ye, Jindan Yu, Li Li, Weiquan Li
Genes & Development. 2008-07-15 - 126 citationsPhosphorylation of Angiomotin by Lats1/2 Kinases Inhibits F-actin Binding, Cell Migration, and AngiogenesisXiaoming Dai, Peilu She, Fangtao Chi, Ying Feng, Huan Liu
The Journal of Biological Chemistry. 2013-11-22 - 188 citationsHeterogeneity of human macrophages in culture and in atherosclerotic plaques.Stephen W. Waldo, Yifu Li, Chiara Buono, Bin Zhao, Eric M. Billings
The American Journal of Pathology. 2008-04-01
Press Mentions
Identification of Key Genes and Pathways in Scleral Extracellular Matrix Remodeling in Glaucoma: Potential Therapeutic Agents Discovered Using Bioinformatics AnalysisFebruary 4th, 2021
Identification of Key Genes and Pathways in Scleral Extracellular Matrix Remodeling in Glaucoma: Potential Therapeutic Agents Discovered Using Bioinformatics AnalysisFebruary 4th, 2021
Holonyak Lab Team Creates Fast, Cheap, Accessible COVID-19 Antibody TestFebruary 1st, 2021- Join now to see all
